Product Images Budesonide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 13 images provide visual information about the product associated with Budesonide NDC 0487-9701 by Nephron Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

bud fig 1

bud fig 1

bud fig 3

bud fig 3

Chemical Structure - budesonide 01

Chemical Structure - budesonide 01

Figure 1 - budesonide 02

Figure 1 - budesonide 02

The text describes the mean change from baseline in nighttime asthma symptoms over a period of 12 weeks for a placebo group and two other treatment groups receiving different doses.*

PRINCIPAL DISPLAY PANEL - 0.25 mg / 2 mL Ampule Carton - budesonide 09

PRINCIPAL DISPLAY PANEL - 0.25 mg / 2 mL Ampule Carton - budesonide 09

This is a prescription medication in a 2mL unit-dose ampule used for inhalation only. It contains 0.25mg of micronized budesonide, which should be used immediately after opening in jet nebulizers only. The medication should be stored at 20°- 25°C (68°-77°F) and protected from light in a foil envelope placed upright in the carton. Instructions for use should be followed as directed by a physician. For further details, check the package insert or call customer service.*

PRINCIPAL DISPLAY PANEL - 0.5 mg / 2 mL Ampule Carton - budesonide 10

PRINCIPAL DISPLAY PANEL - 0.5 mg / 2 mL Ampule Carton - budesonide 10

budesonide 11

budesonide 11

budesonide 12

budesonide 12

budesonide 13

budesonide 13

This is a prescription medication with the NDC code 0487-9701-01. It is for inhalation only and comes in a plastic ampule with a 2 mL sterile suspension that contains 0.5 mg of micronized budesonide. The inactives include citric acid, edetate disodium dihydrate, polysorbate 80, sodium chloride, sodium citrate, and water for injection. The medication should be used as directed by a physician and the package insert should be reviewed for full prescribing information. Once opened, the contents of an ampule should be used immediately. It should be used only in a jet nebulizer and not in an ultrasonic nebulizer. The medication should be stored at controlled room temperature between 20-25°C (68-77°F) and should be protected from light. The medication is manufactured by a company called "Finetherapeutics" located in West Columbia, SC. The product should be kept out of reach of children.*

budesonide 14

budesonide 14

budesonide 15

budesonide 15

budesonide 16

budesonide 16

ifu 04 2020 update

ifu 04 2020 update

This text provides instructions for handling and using Budesonide inhalation suspension. The medication should be stored at room temperature and shaking the ampule before use is recommended. The medication is used with a nebulizer machine and the user should wear an appropriate mask to avoid getting mist in their eyes. Finally, the used ampule should be disposed of properly.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.